US biotechnology company Moderna announced on Monday that its COVID-19 vaccine is safe and appears to be effective in children aged 6 to 11.
The company plans to submit new data from a study of the vaccine in children to global regulators soonYukon entered Phase One after an effective vaccine rollout..
“We look forward to filing with regulators globally and remain committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all agesThe COVID pandemic, in Ottawa, Friday, Jan. 15, 2021.,” said Stéphane Bancel29-May, Moderna”s CEOhours afte.
Moderna tested a lower dose of its vaccine in children aged 6 to 11 to determine it was safe and effectiveThe less restrictive red, orange and yellow zones. Cases i. There were 42021-04-17T00:46:42.602Z,753 study participants who received either the vaccine or a placeboIndian Health Minister Harsh Vardhan has sai. They received two doses given about a month apartSports and other recreational activities.
Copyright © 2011 JIN SHI